Loading Events

« All Events

BioBusiness Insights: Market Drivers in Regenerative Medicine

September 8 @ 9:00 am - 10:00 am AEST

This is Session 4 in the BioBusiness Insights: Opportunities in Regenerative Medicine series. Find out more about about all six sessions, and register for the series at a reduced rate below.

In this session, Paul Brennan, Managing Director of PolyNovo, will share how PolyNovo enters various global markets, how they partner with key opinion leaders in the development of new products and what underlying drivers are used to assess product development priorities.

With a Polymer that can be developed into many different medical devices, how does PolyNovo select from the embarrassment of choice?

Session 4 Details

Date: Tuesday 8 September 2020
Time: 9:00 am – 10:00 am AEST
Format:  This event will be delivered on a virtual platform – you will receive a link to join via a confirmation email following registration.
Registration:
Single session: Members $35; Non-members $45
Complete series (six sessions): Members $150; Non-members $210
Unsure if your organisation is a member? Check our member directory.

Registered? Submit a question for Session 4 ahead of time.

Speaker

Paul Brennan, Managing Director, PolyNovo Limited

Series Facilitator

Silvio Tiziani, CEO, CCRM Australia

 

BioBusiness Insights is delivered in collaboration with the Centre for Commercialization of Regenerative Medicine (CCRM) Australia.

Thanks to our Premier Sponsor for this event series, the State Government of Victoria.

Thanks to our Supporting Sponsor for this event series, Cortellis.

Paul Brennan, Managing Director, PolyNovo Limited

Mr Brennan has extensive knowledge, exposure and understanding of the health system through his clinical background and commercial exposure with various multinational companies. He has coordinated the marketing, global strategy development, new product development and regulatory processes for the Asia-Pacific region for industry-leading organisations in relation to medical products and devices. Mr Brennan has an intimate knowledge of the manufacturing and production processes.
Previously he was Marketing Director Australia and New Zealand and Sales Director New Zealand for Smith & Nephew Healthcare from 2008 to his commencement with PolyNovo in February 2015. Mr Brennan holds a MBA from Swinburne University, a Bachelor of Science (Nursing) from the University of New England in NSW, Certificate in Midwifery Central Coast Area Health Service NSW, and General Nursing certificate from St Vincent’s Hospital Darlinghurst NSW.

Silvio Tiziani, CEO, CCRM Australia

Silvio Tiziani has played a key role in the establishment of Centre for Commercialisation of Regenerative Medicine (CCRM) Australia with the support of Canada’s CCRM, the Victorian Government and MTPConnect. Silvio is also Director, External Strategy and Planning at the Australian Regenerative Medicine Institute (ARMI). Silvio’s extensive knowledge of the research landscape is well utilised with his networks within the industry, international organisations and state and federal governments.
Silvio has extensive experience in private and public organisations, with a focus on laboratory-based services in government, private organisations, healthcare and research/academia.
In addition to qualifications that include a Bachelor of Science from Swinburne University and a Masters of Business Administration from Monash University, Silvio is also a graduate of the Australian Institute of Company Directors (GAICD). Silvio has extensive experience in financial analysis and budget management, business development, strategic planning and corporate governance along with strong interpersonal skills to lead staff.
Silvio also chairs the Ausbiotech Regenerative Medicine Advisory Group. Comprising leading representatives from industry and academia within the Australian regenerative medicine the Group provides specialist advice to Ausbiotech, Australia’s member-based biotechnology organisation, a peak body that promotes the global growth of Australian biotechnology.

Tickets

Member - Virtual Ticket$35.00
Member - Series$150.00
Non Member - Virtual Ticket$45.00
Non Member - Series$210.00

Details

Date:
September 8
Time:
9:00 am - 10:00 am
Cost:
$35 - $210
Event Category:

Contact

BioMelbourne Network
Phone:
+61 3 9667 8181
Email:
info@biomelbourne.org

Home

News & opinion

Member Directory

Events